Teligent Inc (NASDAQ:TLGT) CEO Jason Grenfell-Gardner sold 52,800 shares of the firm’s stock in a transaction that occurred on Tuesday, September 4th. The stock was sold at an average price of $4.00, for a total value of $211,200.00. Following the transaction, the chief executive officer now owns 94,949 shares in the company, valued at approximately $379,796. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
NASDAQ:TLGT traded down $0.16 during mid-day trading on Wednesday, reaching $3.93. 360,600 shares of the stock were exchanged, compared to its average volume of 606,811. The company has a market capitalization of $216.29 million, a PE ratio of -20.68 and a beta of 1.09. The company has a quick ratio of 1.79, a current ratio of 2.77 and a debt-to-equity ratio of 3.31. Teligent Inc has a 1 year low of $2.43 and a 1 year high of $7.34.
A number of research analysts recently issued reports on TLGT shares. Canaccord Genuity set a $4.00 price target on Teligent and gave the stock a “hold” rating in a research note on Wednesday, May 9th. Zacks Investment Research downgraded Teligent from a “hold” rating to a “sell” rating in a research note on Thursday, May 10th. Finally, ValuEngine upgraded Teligent from a “hold” rating to a “buy” rating in a research note on Friday, August 10th.
Large investors have recently added to or reduced their stakes in the stock. Spark Investment Management LLC purchased a new position in Teligent during the 1st quarter worth approximately $162,000. JPMorgan Chase & Co. grew its stake in Teligent by 225.7% during the 1st quarter. JPMorgan Chase & Co. now owns 33,731 shares of the company’s stock worth $274,000 after buying an additional 23,376 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its stake in Teligent by 83.9% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 94,443 shares of the company’s stock worth $327,000 after buying an additional 43,091 shares during the last quarter. Deutsche Bank AG grew its stake in Teligent by 82.5% during the 4th quarter. Deutsche Bank AG now owns 90,938 shares of the company’s stock worth $329,000 after buying an additional 41,119 shares during the last quarter. Finally, Citadel Advisors LLC grew its stake in Teligent by 86.2% during the 1st quarter. Citadel Advisors LLC now owns 114,784 shares of the company’s stock worth $385,000 after buying an additional 53,141 shares during the last quarter. Hedge funds and other institutional investors own 68.76% of the company’s stock.
Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.
Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.